President and Representative Director: Gyo Sagara
Code No: 4528 at the 1st section of the Tokyo Stock Exchange Inquiries: Yukio Tani, Managing Director, Corporate Communications
October 31, 2017
Notice Regarding Completion of Cancellation of Treasury SharesOsaka, Japan, October 31, 2017 - Ono Pharmaceutical Co., Ltd. (President, Representative Director and CEO, Gyo Sagara; "the Company") announced that, as resolved at the meeting of the Board of Directors held on June 13, 2017, it completed cancellation of treasury shares pursuant to the provisions of Article 178 of the Companies Act.
Particulars
Class of shares cancelled: Common stock of the Company
Total number of shares cancelled: 45,896,100 shares
(7.79% of total issued shares prior to cancellation)
Date of cancellation: October 31, 2017
(Reference)
The total number of issued shares (after cancellation) 543,341,400 shares
ONO Pharmaceutical Co. Ltd. published this content on 31 October 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 31 October 2017 04:02:03 UTC.
Original documenthttp://www.ono.co.jp/eng/news/pdf/sm_cn171031_1.pdf
Public permalinkhttp://www.publicnow.com/view/B3F66F7231723684DF6BFFCD915FA13DDCF5219A